🔎 Trials Near Me

Hjem › Lungecancer › Arizona › Gilbert

Lungecancer kliniske forsøg i Gilbert, AZ

8 studier for Lungecancer søger deltagere på steder i og omkring Gilbert (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • Ironwood Cancer & Research Centers, Gilbert
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07222566

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

RekruttererFase 1/2
  • Banner Health- MD Anderson Cancer Center, Gilbert
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT05786924

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • Banner MD Anderson Cancer Center, Gilbert
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Gilbert
Alder 18 til 75 · Alle køn · Opdateret 4. sep. 2026 · NCT07038343

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

RekruttererFase 1/2
  • Banner MD Anderson Cancer Center, Gilbert
Alder 18 og opefter · Alle køn · Opdateret 30. jun. 2026 · NCT06162221

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

RekruttererFase 2
  • Banner Health MD Anderson, Gilbert
Alder 18 til 70 · Alle køn · Opdateret 26. jun. 2026 · NCT04614103

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

RekruttererFase 1/2
  • Banner Health, Gilbert
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT06051695

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

RekruttererFase 1/2
  • Banner MD Anderson Cancer Center, Gilbert
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2025 · NCT06682793

Lungecancer forsøg i andre byer

Andre studier i Gilbert

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.